Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Nilanjan Ganguly"'
Autor:
Juhina Das, Saurav Bera, Nilanjan Ganguly, Ipsita Guha, Tithi Ghosh Halder, Avishek Bhuniya, Partha Nandi, Mohona Chakravarti, Sukanya Dhar, Anirban Sarkar, Tapasi Das, Saptak Banerjee, Sandip Ghose, Anamika Bose, Rathindranath Baral
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/acc7b90f77ea44b38e75bc734607dcb5
Autor:
Nilanjan Ganguly, Tapasi Das, Avishek Bhuniya, Ipsita Guha, Mohona Chakravarti, Sukanya Dhar, Anirban Sarkar, Saurav Bera, Jesmita Dhar, Shayani Dasgupta, Akata Saha, Tithi Ghosh, Juhina Das, Ugir Hossain Sk, Saptak Banerjee, Subrata Laskar, Anamika Bose, Rathindranath Baral
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-26 (2024)
Abstract Background A water-soluble ingredient of mature leaves of the tropical mahogany ‘Neem’ (Azadirachta indica), was identified as glycoprotein, thus being named as ‘Neem Leaf Glycoprotein’ (NLGP). This non-toxic leaf-component regressed
Externí odkaz:
https://doaj.org/article/57ec6b66f76846b985ce042d2195c007
Autor:
Juhina Das, Saurav Bera, Nilanjan Ganguly, Ipsita Guha, Tithi Ghosh Halder, Avishek Bhuniya, Partha Nandi, Mohona Chakravarti, Sukanya Dhar, Anirban Sarkar, Tapasi Das, Saptak Banerjee, Sandip Ghose, Anamika Bose, Rathindranath Baral
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionMurine tumor growth restriction by neem leaf glycoprotein (NLGP) was established in various transplanted models of murine sarcoma, melanoma and carcinoma. However, the role of NLGP in the sequential carcinogenic steps has not been explore
Externí odkaz:
https://doaj.org/article/135df3f8dc1c4a1a8b7e8e4a38eabc10
Autor:
Sukanya Dhar, Mohona Chakravarti, Nilanjan Ganguly, Akata Saha, Shayani Dasgupta, Saurav Bera, Anirban Sarkar, Kamalika Roy, Juhina Das, Avishek Bhuniya, Sarbari Ghosh, Madhurima Sarkar, Srabanti Hajra, Saptak Banerjee, Chiranjib Pal, Bhaskar Saha, Kalyan Kusum Mukherjee, Rathindranath Baral, Anamika Bose
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
IntroductionNon-Hodgkin Lymphoma (NHL) is a heterogeneous lymphoproliferative malignancy with B cell origin. Combinatorial treatment of rituximab, cyclophsphamide, hydroxydaunorubicin, oncovin, prednisone (R-CHOP) is the standard treatment regimen fo
Externí odkaz:
https://doaj.org/article/a75d2feccb1c409f8d704d295c8d36e8
Autor:
Aishwarya Guha, Kuntal Kanti Goswami, Jasmine Sultana, Nilanjan Ganguly, Pritha Roy Choudhury, Mohona Chakravarti, Avishek Bhuniya, Anirban Sarkar, Saurav Bera, Sukanya Dhar, Juhina Das, Tapasi Das, Rathindranath Baral, Anamika Bose, Saptak Banerjee
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Breast cancer (BC) is globally one of the leading killers among women. Within a breast tumor, a minor population of transformed cells accountable for drug resistance, survival, and metastasis is known as breast cancer stem cells (BCSCs). Several expe
Externí odkaz:
https://doaj.org/article/ee917681f6e343c6b9ece601826f977c
Autor:
Tithi Ghosh, Partha Nandi, Nilanjan Ganguly, Ipsita Guha, Avishek Bhuniya, Sarbari Ghosh, Anirban Sarkar, Akata Saha, Shayani Dasgupta, Rathindranath Baral, Anamika Bose
Publikováno v:
Stem Cell Research & Therapy, Vol 10, Iss 1, Pp 1-12 (2019)
Abstract Background A dynamic interaction between tumor cells and its surrounding stroma promotes the initiation, progression, metastasis, and chemoresistance of solid tumors. Emerging evidences suggest that targeting the stromal events could improve
Externí odkaz:
https://doaj.org/article/8478476d8ec84887a03e0fa1aaa0f5f9
Autor:
Ipsita Guha, Avishek Bhuniya, Divanshu Shukla, Ashok Patidar, Partha Nandi, Akata Saha, Shayani Dasgupta, Nilanjan Ganguly, Sweta Ghosh, Arathi Nair, Subrata Majumdar, Bhaskar Saha, Walter J. Storkus, Rathindranath Baral, Anamika Bose
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Tumor progression in the host leads to severe impairment of intrathymic T-cell differentiation/maturation, leading to the paralysis of cellular anti-tumor immunity. Such suppression manifests the erosion of CD4+CD8+ double-positive (DP) immature thym
Externí odkaz:
https://doaj.org/article/37ba96d9fed24e6ea859717dbfe99e7c
Autor:
Avishek Bhuniya, Ipsita Guha, Nilanjan Ganguly, Akata Saha, Shayani Dasgupta, Partha Nandi, Arnab Das, Sarbari Ghosh, Tithi Ghosh, Enamul Haque, Saptak Banerjee, Anamika Bose, Rathindranath Baral
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Neem leaf glycoprotein (NLGP), a natural immunomodulator, attenuates murine carcinoma and melanoma metastasis, independent of primary tumor growth and alterations in basic cellular properties (cell proliferation, cytokine secretion, etc.). Colonizati
Externí odkaz:
https://doaj.org/article/3c133330613847afa25db14f00112c68
Autor:
Akata Saha, Partha Nandi, Shayani Dasgupta, Avishek Bhuniya, Nilanjan Ganguly, Tithi Ghosh, Ipsita Guha, Saptak Banerjee, Rathindranath Baral, Anamika Bose
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Neem Leaf Glycoprotein (NLGP) is a natural immunomodulator, have shown sustained tumor growth restriction as well as angiogenic normalization chiefly by activating CD8+ T cells. Here, we have investigated the direct role of NLGP as a regulator of tum
Externí odkaz:
https://doaj.org/article/0b406fb8487b454fba6ed55e48a6c21d
Autor:
Madhurima Sarkar, Smarajit Pal, Anirban Sarkar, Akata Saha, Tapasi Das, Swapan Kr Ghosh, Mohona Chakravarti, Ipsita Guha, Avishek Bhuniya, Sukanya Dhar, Saurav Bera, Sarbari Ghosh, Rathindranath Baral, Anamika Bose, Saptak Banerjee, Nilanjan Ganguly, Shayani Dasgupta
Publikováno v:
Melanoma Research. 31:130-139
Myeloid-derived suppressor cells (MDSCs) suppress antitumor immune functions. We have observed that an immunomodulator, neem leaf glycoprotein (NLGP), inhibits tumor-resident MDSCs and enhances antitumor CD8+ T cell immunity. NLGP inhibits the number
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5011873141e0b0193b6e3d56f12de525
https://doi.org/10.1097/cmr.0000000000000721
https://doi.org/10.1097/cmr.0000000000000721